Minimal impact of selective susceptibility reporting on the use of piperacillin-tazobactam for Escherichia coli and Klebsiella bacteremia

Selective cascade reporting of antibiotic susceptibilities did not have a significant impact on de-escalation from piperacillin-tazobactam (PT), duration of PT use, length of stay, or rates of acute kidney injury and Clostridioides difficile infection in patients with positive monomicrobial blood cu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zahlanie, Yorgo, Hall, Brenton C., Wei, Wenjing, Mang, Norman S., Ortwine, Jessica K., Anderson, Shelby, Morgan, Kristi, Guzman, Tamara P., Hynan, Linda S., Prokesch, Bonnie C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Concise Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506344/
https://www.ncbi.nlm.nih.gov/pubmed/33423705
http://dx.doi.org/10.1017/ice.2020.1385
_version_ 1784581705550528512
author Zahlanie, Yorgo
Hall, Brenton C.
Wei, Wenjing
Mang, Norman S.
Ortwine, Jessica K.
Anderson, Shelby
Morgan, Kristi
Guzman, Tamara P.
Hynan, Linda S.
Prokesch, Bonnie C.
author_facet Zahlanie, Yorgo
Hall, Brenton C.
Wei, Wenjing
Mang, Norman S.
Ortwine, Jessica K.
Anderson, Shelby
Morgan, Kristi
Guzman, Tamara P.
Hynan, Linda S.
Prokesch, Bonnie C.
author_sort Zahlanie, Yorgo
collection PubMed
description Selective cascade reporting of antibiotic susceptibilities did not have a significant impact on de-escalation from piperacillin-tazobactam (PT), duration of PT use, length of stay, or rates of acute kidney injury and Clostridioides difficile infection in patients with positive monomicrobial blood cultures with either Escherichia coli or Klebsiella spp.
format Online
Article
Text
id pubmed-8506344
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-85063442021-10-22 Minimal impact of selective susceptibility reporting on the use of piperacillin-tazobactam for Escherichia coli and Klebsiella bacteremia Zahlanie, Yorgo Hall, Brenton C. Wei, Wenjing Mang, Norman S. Ortwine, Jessica K. Anderson, Shelby Morgan, Kristi Guzman, Tamara P. Hynan, Linda S. Prokesch, Bonnie C. Infect Control Hosp Epidemiol Concise Communication Selective cascade reporting of antibiotic susceptibilities did not have a significant impact on de-escalation from piperacillin-tazobactam (PT), duration of PT use, length of stay, or rates of acute kidney injury and Clostridioides difficile infection in patients with positive monomicrobial blood cultures with either Escherichia coli or Klebsiella spp. Cambridge University Press 2021-10 2021-01-11 /pmc/articles/PMC8506344/ /pubmed/33423705 http://dx.doi.org/10.1017/ice.2020.1385 Text en © The Society for Healthcare Epidemiology of America 2021 https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
spellingShingle Concise Communication
Zahlanie, Yorgo
Hall, Brenton C.
Wei, Wenjing
Mang, Norman S.
Ortwine, Jessica K.
Anderson, Shelby
Morgan, Kristi
Guzman, Tamara P.
Hynan, Linda S.
Prokesch, Bonnie C.
Minimal impact of selective susceptibility reporting on the use of piperacillin-tazobactam for Escherichia coli and Klebsiella bacteremia
title Minimal impact of selective susceptibility reporting on the use of piperacillin-tazobactam for Escherichia coli and Klebsiella bacteremia
title_full Minimal impact of selective susceptibility reporting on the use of piperacillin-tazobactam for Escherichia coli and Klebsiella bacteremia
title_fullStr Minimal impact of selective susceptibility reporting on the use of piperacillin-tazobactam for Escherichia coli and Klebsiella bacteremia
title_full_unstemmed Minimal impact of selective susceptibility reporting on the use of piperacillin-tazobactam for Escherichia coli and Klebsiella bacteremia
title_short Minimal impact of selective susceptibility reporting on the use of piperacillin-tazobactam for Escherichia coli and Klebsiella bacteremia
title_sort minimal impact of selective susceptibility reporting on the use of piperacillin-tazobactam for escherichia coli and klebsiella bacteremia
topic Concise Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506344/
https://www.ncbi.nlm.nih.gov/pubmed/33423705
http://dx.doi.org/10.1017/ice.2020.1385
work_keys_str_mv AT zahlanieyorgo minimalimpactofselectivesusceptibilityreportingontheuseofpiperacillintazobactamforescherichiacoliandklebsiellabacteremia
AT hallbrentonc minimalimpactofselectivesusceptibilityreportingontheuseofpiperacillintazobactamforescherichiacoliandklebsiellabacteremia
AT weiwenjing minimalimpactofselectivesusceptibilityreportingontheuseofpiperacillintazobactamforescherichiacoliandklebsiellabacteremia
AT mangnormans minimalimpactofselectivesusceptibilityreportingontheuseofpiperacillintazobactamforescherichiacoliandklebsiellabacteremia
AT ortwinejessicak minimalimpactofselectivesusceptibilityreportingontheuseofpiperacillintazobactamforescherichiacoliandklebsiellabacteremia
AT andersonshelby minimalimpactofselectivesusceptibilityreportingontheuseofpiperacillintazobactamforescherichiacoliandklebsiellabacteremia
AT morgankristi minimalimpactofselectivesusceptibilityreportingontheuseofpiperacillintazobactamforescherichiacoliandklebsiellabacteremia
AT guzmantamarap minimalimpactofselectivesusceptibilityreportingontheuseofpiperacillintazobactamforescherichiacoliandklebsiellabacteremia
AT hynanlindas minimalimpactofselectivesusceptibilityreportingontheuseofpiperacillintazobactamforescherichiacoliandklebsiellabacteremia
AT prokeschbonniec minimalimpactofselectivesusceptibilityreportingontheuseofpiperacillintazobactamforescherichiacoliandklebsiellabacteremia

Ejemplares similares